sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
5-May-2016 04:42
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 76-100 out of 1225.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>

Public Release: 29-Mar-2016
Proceedings of the National Academy of Sciences
Scientists unlock genetic secret that could help fight malaria
A group of scientists, including one from the University of California, Riverside, have discovered a long-hypothesized male determining gene in the mosquito species that carries malaria, laying the groundwork for the development of strategies that could help control the disease.

Contact: Sean Nealon
sean.nealon@ucr.edu
951-827-1287
University of California - Riverside

Public Release: 28-Mar-2016
Proceedings of the National Academy of Sciences
New drug combinations could significantly improve tuberculosis treatment
Researchers from UCLA and Shanghai Jiao Tong University have made an important step toward a substantially faster and more effective treatment for tuberculosis, which infects some 10 million people and causes 1.5 million deaths each year.

Contact: Matthew Chin
mchin@support.ucla.edu
310-206-0680
University of California - Los Angeles

Public Release: 28-Mar-2016
Preventive Medicine
Study offers efficient alternative for Ebola screening program for travelers
As of Jan. 31, 2016, a total of 28,639 cases and 11,316 deaths have been attributed to Ebola, figures that may significantly underestimate the actual scope of the 2014 outbreak in West Africa. One strategy recommended by the WHO required exit screening at airports for passengers who depart from countries with Ebola. Researchers from the University of Illinois at Urbana-Champaign provide an alternative policy for Ebola entry screening at airports in the United States.

Contact: Sheldon H. Jacobson
shj@illinois.edu
217-244-7275
University of Illinois College of Engineering

Public Release: 28-Mar-2016
American Entomologist
An ancient killer: Ancestral malarial organisms traced to age of dinosaurs
A new analysis of the prehistoric origin of malaria suggests that it evolved in insects at least 100 million years ago, and the first vertebrate hosts of this disease were probably reptiles, which at that time would have included the dinosaurs. Researchers say it may have been involved in their extinction.

Contact: George Poinar, Jr.
poinarg@science.oregonstate.edu
Oregon State University

Public Release: 28-Mar-2016
Nature Chemical Biology
Stanford scientists resurrect an abandoned drug, find it effective against human viruses
Stanford scientists have resurrected a discarded drug that helps human cells in a lab dish fight off two different viruses. Based on what they learned about how the drug works, it might also help fight the viruses that cause Ebola, dengue and Zika, among others.
National Science Foundation Graduate Research Fellowship, Burt and Deedee McMurtry Stanford Graduate Fellowship, National Institutes of Health, Director's New Innovator Award Program, Stanford ChEM-H

Contact: Amy Adams
amyadams@stanford.edu
650-796-3695
Stanford University

Public Release: 28-Mar-2016
American Journal of Tropical Medicine and Hygiene
New mouse model for Zika virus to enable immediate screening of potential drugs and vaccines
Researchers at the University of Texas Medical Branch, Galveston announce the first peer-reviewed mouse model for Zika infection reported in decades. Until now a mouse model -- a critical stage in preclinical testing -- has not been available for research institutions and companies with vaccine and drug candidates in the pipeline. The study, published in the American Journal of Tropical Medicine and Hygiene, removes a treatment screening bottleneck.

Contact: Bridget DeSimone
bdesimone@burness.com
301-280-5735
Burness

Public Release: 24-Mar-2016
EGPAF wins award to scale up innovative PMTCT medications in Uganda
The Elizabeth Glaser Pediatric AIDS Foundation has been selected to receive the prestigious Saving Lives at Birth: A Grand Challenge for Development Award for its model to nationally scale up use of the innovative 'Pratt Pouch' to prevent mother-to-child transmission of HIV in Uganda. EGPAF's model will introduce the easy-to-use pouches during antenatal care, delivery, and postnatal care services in Uganda with the goal of reaching 40,000 infants in three years.
Grand Challenges

Contact: Johanna Harvey
jharvey@pedaids.org
202-280-1657
Elizabeth Glaser Pediatric AIDS Foundation

Public Release: 24-Mar-2016
World TB Day: Medical trial to tackle tuberculosis in South Africa
Researchers from the University of Liverpool have been awarded a grant worth more than £400,000 to conduct a medical trial focused on controlling tuberculosis epidemics in South Africa.
Medical Research Council

Contact: Simon Wood
44-151-794-8356
University of Liverpool

Public Release: 23-Mar-2016
PLOS ONE
Sterile Box offers safer surgeries
A Rice University team validates its Sterile Box, a mobile, solar-powered facility to sterilize surgical instruments in low-resource settings.

Contact: David Ruth
david@rice.edu
713-348-6327
Rice University

Public Release: 23-Mar-2016
Lancet HIV
Botswana study shows 96 percent rate of viral suppression for patients on HIV drugs
Botswana appears to have achieved very high rates of HIV diagnosis, treatment, and viral suppression -- much better than most Western nations, including the United States -- according to a new study from Harvard T.H. Chan School of Public Health and colleagues in Botswana.
US Centers for Disease Control and Prevention

Contact: Todd Datz
tdatz@hsph.harvard.edu
617-432-8413
Harvard T.H. Chan School of Public Health

Public Release: 23-Mar-2016
Molecular Phylogenetics and Evolution
Field Museum study reveals evolution of malaria
A Field Museum study published today in Molecular Phylogenetics and Evolution reveals a new take on the evolution of different malaria species and contributes to the ongoing search for the origins of malaria in humans. The analysis, the most complete of its kind on malaria to date, revealed that malaria has its roots in bird hosts, from which it spread to bats, and then on to other mammals.

Contact: Kate Golembiewski
media@fieldmuseum.org
312-665-7100
Field Museum

Public Release: 22-Mar-2016
Proceedings of the Royal Society B
Mixed-strain malaria infections influence drug resistance
When hosts are co-infected with drug-resistant and drug-sensitive strains, both strains are competitively suppressed. Anti-malarial therapy, by clearing the drug-sensitive parasites from mixed infections, may result in competitive release of resistant strains.
Burroughs Wellcome Fund Institutional Program Unifying Population and Laboratory-based Science, Emory University, Association of Public Health Laboratories, US Centers for Disease Control and Prevention, National Institutes of Health

Contact: Carol Clark
carol.clark@emory.edu
404-727-0501
Emory Health Sciences

Public Release: 22-Mar-2016
Lancet Infectious Diseases
Global spread of Zika linked to types of mosquitos that transmit it
More cities than previously assumed could soon grapple with the Zika virus if two species of mosquitos are found to be equally effective carriers of the disease, a University of Texas at Austin disease ecologist and his colleagues argue in the current edition of The Lancet Infectious Diseases.

Contact: Christine Sinatra
christine.sinatra@austin.utexas.edu
512-853-0506
University of Texas at Austin

Public Release: 22-Mar-2016
eLife
Deadly flatworm's skin rejuvenation may explain its long-term survival in humans
A parasitic flatworm that infects hundreds of millions of people in the developing world is able to survive in the bloodstream for decades by constantly renewing its skin - a mechanism that could inform potential new treatments against infection.
Howard Hughes Medical Institute, National Institutes of Health

Contact: Emily Packer
e.packer@elifesciences.org
eLife

Public Release: 22-Mar-2016
Nature Communications
Genomes of chimpanzee parasite species reveal evolution of human malaria
An international team used an amplification technique to sequence the genomes of two divergent Plasmodium malaria species from miniscule volumes of chimpanzee blood to find clues about the evolution and pathogenicity of Plasmodium falciparum, the deadliest malaria parasite that affects people. Understanding the origins of emerging diseases -- and more established disease agents -- is critical to gauge future human infection risks and find new treatment and prevention approaches.
National Institutes of Health, Burroughs Wellcome Fund, Agence Nationale de Recherche sur le Sida, Agence Nationale de Recherche, and Wellcome Trust

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine

Public Release: 21-Mar-2016
ESMO Open
Back to the essence of medical treatment in oncology
The latest article to appear on ESMO Open highlights ESMO's hope that the 2015 WHO Model List of Essential Medicines will empower oncologists and advocates to demand routine availability of the medicines considered essential to guarantee quality care of cancer patients

Contact: ESMO Press Office
media@esmo.org
41-919-731-904
European Society for Medical Oncology

Public Release: 21-Mar-2016
Nature Microbiology
Genomic study of epidemic dysentery reveals how Europe exported a scourge worldwide
The largest genetic study on the bacterium responsible for epidemic dysentery has revealed that the Shigella dysenteriae pathogen, which remains a real scourge in Africa and Asia, probably originated in Europe. This research, which was carried out by scientists from the Wellcome Trust Sanger Institute and Institut Pasteur in Paris, also charts the development of the pathogen's resistance to antibiotics, and is published in the journal Nature Microbiology.
Institut Pasteur, Institut Pasteur International Network, InVS, IBEID Laboratory of Excellence, Le Roch Les Mousquetaires Foundation, and Wellcome Trust

Contact: Samantha Wynne
press.office@sanger.ac.uk
122-349-2368
Wellcome Trust Sanger Institute

Public Release: 18-Mar-2016
American Journal of Pathology
New gene identified as cause, early indicator of breast cancer
When mutated, a gene known for its ability to repair DNA, appears to instead cause breast cancer, scientists report.

Contact: Toni Baker
tbaker@augusta.edu
706-721-4421
Medical College of Georgia at Augusta University

Public Release: 17-Mar-2016
The Lancet
Treating HIV patients at risk for tuberculosis with TB drugs doesn't save more lives
Treating HIV patients at risk for tuberculosis with multi-drug TB regimens does not save more lives, researchers from Penn Medicine and other institutions report in The Lancet.
NIH/National Institutes of Allergy and Infectious Diseases

Contact: Steve Graff
stephen.graff@uphs.upenn.edu
215-349-5653
University of Pennsylvania School of Medicine

Public Release: 16-Mar-2016
PLOS Currents: Outbreaks
Potential Zika virus risk estimated for 50 US cities
The Aedes aegypti mosquito, which is spreading the virus in much of Latin America and the Caribbean, will likely become increasingly abundant across much of the southern and eastern United States as the weather warms, according to a new study led by mosquito and disease experts at the National Center for Atmospheric Research in Boulder, Colorado.
National Science Foundation

Contact: Cheryl Dybas
cdybas@nsf.gov
703-292-7734
National Science Foundation

Public Release: 16-Mar-2016
Science Translational Medicine
Experimental dengue vaccine protects all recipients in virus challenge study
A clinical trial in which volunteers were infected with dengue virus six months after receiving either an experimental dengue vaccine developed by scientists from NIH or a placebo injection yielded starkly contrasting results. All 21 volunteers who received the vaccine, TV003, were protected from infection, while all 20 placebo recipients developed infection. The study underscores the importance of human challenge studies, in which volunteers are exposed to disease-causing pathogens under carefully controlled conditions.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 16-Mar-2016
Science Translational Medicine
Vermont Vaccine Testing Center study reveals effective, single-dose dengue vaccine
Results from a dengue vaccine virus challenge study show 100 percent protection in clinical trial participants tested at University of Vermont and Johns Hopkins University.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jennifer Nachbur
jennifer.nachbur@uvm.edu
802-656-7875
University of Vermont

Public Release: 16-Mar-2016
Science Translational Medicine
Last piece of dengue vaccine puzzle found effective in small trial
In a small clinical trial led by the Johns Hopkins Bloomberg School of Public Health, researchers say that a promising single-dose dengue vaccine, developed by scientists at the National Institutes of Health, was 100 percent effective in preventing human volunteers from contacting the virus, the most prevalent mosquito-borne virus in the world.
NIH/National Institute of Allergy and Infectious Diseases' Intramural Research Program

Contact: Stephanie Desmon
sdesmon1@jhu.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health

Public Release: 11-Mar-2016
Nature Protocols
Differential immuno-capture biochip offers specific leukocyte counting for HIV diagnosis
Researchers from the University of Illinois at Urbana-Champaign have developed a highly sensitive biosensor based on a differential immuno-capture technology that can detect sub-populations of white blood cells. As part of a small, disposable biochip, the microfluidic biosensor can count CD4+/CD8+ T cells quickly and accurately for AIDS diagnosis in the field.

Contact: Rashid Bashir
rbashir@illinois.edu
217-333-3097
University of Illinois College of Engineering

Public Release: 10-Mar-2016
PLOS Pathogens
Patterns of brain swelling may explain susceptibility of children to cerebral malaria
Brain swelling is a strong predictor of death in children with cerebral malaria (a severe form of the disease where parasites have accumulated in brain vessels), and also in mice with experimental cerebral malaria. A high-resolution whole brain imaging analysis of swelling in ECM published on March 10 in PLOS Pathogens suggests that cerebral malaria depends on the permissive environment in a specific brain area.

Contact: Angelika Hoffmann
angelika.hoffmann@med.uni-heidelberg.de
PLOS

Showing releases 76-100 out of 1225.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>